Advertisement
Screener

10x Genomics, Inc. (TXG) Payments for Restructuring

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Payments for Restructuring

10x Genomics, Inc. (TXG) reported Payments for Restructuring of $7.74 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsForRestructuring · last filed 2026-02-13

  • 10x Genomics, Inc. payments for restructuring for the quarter ending 2025-12-31 was $2.10M.
  • 10x Genomics, Inc. payments for restructuring for the quarter ending 2025-09-30 was $2.63M.
  • 10x Genomics, Inc. payments for restructuring for the quarter ending 2025-06-30 was $3.00M.
  • 10x Genomics, Inc. payments for restructuring for the quarter ending 2025-03-31 was $0.00.
  • 10x Genomics, Inc. payments for restructuring for fiscal 2025 was $7.74M, a 1259.58% increase from fiscal 2024.
  • 10x Genomics, Inc. payments for restructuring for fiscal 2024 was $569.00K, a 164.65% increase from fiscal 2023.
  • 10x Genomics, Inc. payments for restructuring for fiscal 2023 was $215.00K, a 93.65% decline from fiscal 2022.
  • 10x Genomics, Inc. payments for restructuring for fiscal 2022 was $3.38M.
Period endPayments for Restructuring 3 monthPayments for Restructuring 6 monthPayments for Restructuring 9 monthPayments for Restructuring 12 month
2025-12-31$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$4.73M
derived: sum of 2 quarters · filed 2026-02-13
$7.74M
derived: sum of 3 quarters · filed 2026-02-13
$7.74M
10-K · filed 2026-02-13
2025-09-30$2.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$5.63M
derived: sum of 2 quarters · filed 2025-11-07
$5.63M
10-Q · filed 2025-11-07
2025-06-30$3.00M
10-Q · filed 2025-08-08
$3.00M
10-Q · filed 2025-08-08
2025-03-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2026-02-13
2024-12-31$569.00K
10-K · filed 2026-02-13
2023-12-31$215.00K
10-K · filed 2026-02-13
2022-12-31$547.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$3.38M
10-K · filed 2025-02-13
2022-09-30$2.84M
10-Q · filed 2022-11-03